UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549FORM 25 NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER...
FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...
Zosano Pharma Corp false 0001587221 0001587221 2022-05-26 2022-05-26 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington...
FREMONT, Calif., June 02, 2022 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage...
Zosano Pharma Corp false 0001587221 0001587221 2022-05-16 2022-05-16 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington...
false3-312022Q10001587221http://fasb.org/us-gaap/2021-01-31#ServiceMemberhttp://fasb.org/us-gaap/2021-01-31#ServiceMemberhttp://fasb.org/us-gaap/20...
FALSE000158722100015872212021-03-112021-03-11UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549 FORM...
FREMONT, Calif., May 13, 2022 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage...
Zosano Pharma Corp false 0001587221 0001587221 2022-05-03 2022-05-03 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington...
false2021FY000158722100015872212021-01-012021-12-3100015872212021-06-30iso4217:USD00015872212022-03-07xbrli:sharesTable of ContentsIndex to...
FREMONT, Calif., April 29, 2022 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage...
FREMONT, Calif., April 11, 2022 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage...
As filed with the Securities and Exchange Commission on April 1, 2022 Registration No. 333- &nbs...
In a report released yesterday, Anthony Vendetti from Maxim Group maintained a Buy rating on Zosano Pharma (ZSAN – Research Report), with a price...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.